Merck Entered into a WW Research Collaboration and License Agreement with Synthekine to Develop Novel Cytokine Therapeutics
Shots: Synthekine to receive up front along with an additional one-time payment, if selects a second target & will be eligible for ~$525M in development, regulatory, and commercialization milestones along with royalties on net sales for each target Merck to get exclusive rights to develop, manufacture, and commercialize surrogate cytokine agonists for up to two […]